The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBON.L Regulatory News (BON)

  • There is currently no data for BON

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Document Posted

25 Apr 2019 18:00

RNS Number : 1598X
Spectre Holdings Limited
25 April 2019
 

 

 

 

ANNOUNCEMENT - FOR IMMEDIATE RELEASE

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM THE USA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

25 April 2019

 

 

MANDATORY UNCONDITIONAL CASH OFFER

 

by

 

SPECTRE HOLDINGS LIMITED

 

to acquire the entire issued share capital

 

of

 

BONMARCHÉ HOLDINGS PLC

 

1. Posting of Offer Document in respect of Mandatory Unconditional Cash Offer

On 2 April 2019, Spectre Holdings Limited ("Spectre") announced an unconditional mandatory cash offer under Rule 9 of the Takeover Code to acquire the entire issued and to be issued share capital of Bonmarché Holdings plc ("Bonmarché") not already owned by it or by parties acting in concert with it, at a price of 11.445 pence per Bonmarché Share (the "Offer").

Spectre announces that it has today posted to Bonmarché Shareholders an offer document containing the full terms of the Offer (the "Offer Document") together with a Form of Acceptance (in respect of Bonmarché Shares held in certificated form). The Offer Document and Form of Acceptance will also shortly be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on the website of Spectre Holdings Limited (www.spectredxb.com).

2. Timetable

The Offer will initially remain open for acceptance until 1:00 p.m. (London time) on 16 May 2019. Further details of the Offer and the action to be taken to accept the Offer are set out in the Offer Document and the Form of Acceptance.

3. General

Capitalised terms used but not defined in this announcement have the same meanings as given to them in the Offer Document. This announcement should be read by Bonmarché Shareholders in conjunction with the Offer Document and, in respect of Bonmarché Shares held in certificated form, the Form of Acceptance.

Enquiries:

Zeus Capital Limited

(Financial Adviser to Spectre)

+44 (0) 161 831 1512

Tremayne Ducker

Nick Cowles

 

 

A copy of this announcement will be available at www.spectredxb.com. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Zeus Capital, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Spectre and no one else in connection with the Offer and will not be responsible to anyone other than Spectre for providing the protections afforded to its clients, nor for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to in this announcement.

The directors of Spectre and Philip Day accept responsibility for the information contained in this announcement. To the best of their knowledge and belief (having taken all reasonable care to ensure that such is the case), the information contained in this announcement (other than any information relating to Bonmarché, Bonmarché's directors or their immediate families, related trusts and connected persons) for which they are responsible is in accordance with the facts and does not omit anything likely to affect the import of such information.

This announcement is not intended to and does not constitute, or form any part of, an offer or an invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Offer or otherwise, nor shall there be any sale, issuance or transfer of securities of Bonmarché in any jurisdiction in contravention of applicable law. This announcement does not constitute a prospectus or equivalent document. The Offer will be made solely through the Offer Document, which will contain the full terms of the Offer, including details of how to accept the Offer. Any acceptance or other response to the Offer should be made only on the basis of the information contained in the Offer Document. The laws of relevant jurisdictions may affect the availability of the Offer to persons not resident in the United Kingdom. Persons who are not resident in the United Kingdom, or who are subject to the laws of any jurisdiction other than the United Kingdom, should inform themselves about and observe any applicable legal and regulatory requirements. The Offer Document will be available for public inspection and also be available on the website of Spectre (www.spectredxb.com).

Unless otherwise determined by Spectre and permitted by applicable law and regulation, the Offer will not be made, directly or indirectly, in or into the United States or by use of the mails of, or by any means (including, without limitation, facsimile or other electronic transmission, telex or telephone) or instrumentality of inter-state or foreign commerce of, or any facility of, a national, state or other securities exchange of, the United States, nor will it be made directly or indirectly in or into Canada, Australia or Japan and the Offer will not be capable of acceptance by any such use, means, instrumentality or facility or from within the United States, Canada, Australia or Japan or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction. Accordingly, unless otherwise determined by Spectre and permitted by applicable law and regulation, copies of this announcement are not being, will not be and must not be mailed or otherwise forwarded, distributed or sent in, into or from the USA, Canada, Australia or Japan or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction and persons receiving this announcement (including without limitation custodians, nominees and trustees) must not mail, forward, distribute or send them in, into or from the USA, Canada, Australia or Japan or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.

This announcement, including information included or incorporated by reference in this announcement, may contain "forward-looking statements" concerning Spectre and Bonmarché. All statements other than statements of historical fact may be forward-looking statements. Generally, the words "will", "may", "should", "continue", "believes", "expects", "intends", "anticipates" or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the companies' abilities to control or estimate precisely, such as future market conditions and the behaviours of other market participants, and therefore undue reliance should not be placed on such statements, which speak only as of the date of this announcement. Spectre assumes no obligation and does not intend to update these forward-looking statements, except as required pursuant to applicable law.

Please be aware that addresses, electronic addresses and certain other information provided by Bonmarché Shareholders and other relevant persons in connection with the receipt of communications from Bonmarché may be provided to Spectre during the offer period as required under Section 4 of Appendix 4 of the Takeover Code.

Disclosure requirements of the Takeover Code

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3. Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0) 20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on Website

In accordance with Rule 26.1 of the Takeover Code, a copy of this announcement together with all information incorporated into this announcement by reference to another source will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Spectre's website (www.spectredxb.com) by no later than 12 noon (London time) on the Business Day following the publication of this announcement. For the avoidance of doubt, the contents of the website are not incorporated by reference and do not form part of this announcement.

You may request a hard copy of this announcement (and any information incorporated by reference in this announcement) by calling Zeus Capital on +44 (0) 161 831 1512. It is important that you note that unless you make a request, a hard copy of this announcement and any such information incorporated by reference in it will not be sent to you. You may also request that all future documents, announcements and information to be sent to you in relation to the Offer should be in hard copy form.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ODPUVANRKOASUAR
Date   Source Headline
22nd Jun 20154:40 pmRNSHolding(s) in Company
19th Jun 20154:10 pmRNSDirector Declaration
12th Jun 20157:00 amRNSFinal Results
5th Jun 20152:16 pmRNSHolding(s) in Company
7th May 20153:16 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
6th May 20153:50 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
29th Apr 20157:01 amRNSDirectorate Change
10th Apr 20157:00 amRNSTrading Update
15th Jan 20157:00 amRNSTrading Statement
1st Dec 20147:00 amRNSInterim Results
27th Oct 20147:00 amRNSNotice of Results
8th Oct 201411:16 amRNSHolding(s) in Company
7th Oct 20143:13 pmRNSHolding(s) in Company
31st Jul 20143:26 pmRNSResult of AGM
31st Jul 20147:00 amRNSTrading Update
22nd Jul 201411:22 amRNSHolding(s) in Company
9th Jul 20148:56 amRNSHolding(s) in Company
2nd Jul 20147:00 amRNSAnnual Financial Report
19th Jun 20149:22 amRNSHolding(s) in Company
13th Jun 20147:00 amRNSPreliminary Results
11th Apr 20147:00 amRNSTrading Update
27th Mar 20141:35 pmRNSHolding(s) in Company
3rd Feb 20144:07 pmRNSHolding(s) in Company
3rd Feb 201410:48 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSTrading Statement
9th Jan 20149:22 amRNSHolding(s) in Company
7th Jan 20143:00 pmRNSHolding(s) in Company
2nd Jan 20144:24 pmRNSHolding(s) in Company
23rd Dec 201310:56 amRNSHolding(s) in Company
10th Dec 20135:00 pmRNSHolding(s) in Company
22nd Nov 20137:00 amRNSHolding(s) in Company
21st Nov 20133:42 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSFirst day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.